Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.Peter T. Masiakos, Patricia K. Donahoe, Jose M. Teixeira et al.|PubMed|1999Cited by 122